About Freenome
The Problem Freenome addresses a core personal healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Freenome brings accurate and non-invasive disease screening to proactively treat cancer Personal Healthcare Biotech In practice, Freenome centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Freenome is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on personal healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Freenome matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Freenome is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series E • Andreessen Horowitz, Founders Fund, $254M Series E in 2024, $2.6B valuation
Hiring Roles
This company is actively hiring.
Meet the Founders
Freenome Team
Founder & CEO